Massimiliano Ruscica1, Chiara Pavanello2, Sara Gandini3, Monica Gomaraschi2, Cecilia Vitali2, Chiara Macchi4, Beatrice Morlotti5, Gilda Aiello6, Raffaella Bosisio5, Laura Calabresi2, Anna Arnoldi6, Cesare R Sirtori5, Paolo Magni7. 1. Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. massimiliano.ruscica@unimi.it. 2. Centro Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. 3. Division of Epidemiology and Biostatistics, European Institute of Oncology, 20146, Milan, Italy. 4. Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. 5. Centro Dislipidemie, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy. 6. Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Milan, Italy. 7. Centro Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. paolo.magni@unimi.it.
Abstract
BACKGROUND: Cardiovascular diseases are currently the commonest cause of death worldwide. Different strategies for their primary prevention have been planned, taking into account the main known risk factors, which include an atherogenic lipid profile and visceral fat excess. METHODS: The study was designed as a randomized, parallel, single-center study with a nutritional intervention duration of 12 weeks. Whole soy foods corresponding to 30 g/day soy protein were given in substitution of animal foods containing the same protein amount. RESULTS:Soy nutritional intervention resulted in a reduction in the number of MetS features in 13/26 subjects. Moreover, in the soy group we observed a significant improvement of median percentage changes for body weight (-1.5 %) and BMI (-1.5 %), as well as for atherogenic lipid markers, namely TC (-4.85 %), LDL-C (-5.25 %), non-HDL-C (-7.14 %) and apoB (-14.8 %). Since the majority of the studied variables were strongly correlated, three factors were identified which explained the majority (52 %) of the total variance in the whole data set. Among them, factor 1, which loaded lipid and adipose variables, explained the 22 % of total variance, showing a statistically significant difference between treatment arms (p = 0.002). CONCLUSIONS: The inclusion of whole soy foods (corresponding to 30 g/day protein) in a lipid-lowering diet significantly improved a relevant set of biomarkers associated with cardiovascular risk.
RCT Entities:
BACKGROUND:Cardiovascular diseases are currently the commonest cause of death worldwide. Different strategies for their primary prevention have been planned, taking into account the main known risk factors, which include an atherogenic lipid profile and visceral fat excess. METHODS: The study was designed as a randomized, parallel, single-center study with a nutritional intervention duration of 12 weeks. Whole soy foods corresponding to 30 g/day soy protein were given in substitution of animal foods containing the same protein amount. RESULTS: Soy nutritional intervention resulted in a reduction in the number of MetS features in 13/26 subjects. Moreover, in the soy group we observed a significant improvement of median percentage changes for body weight (-1.5 %) and BMI (-1.5 %), as well as for atherogenic lipid markers, namely TC (-4.85 %), LDL-C (-5.25 %), non-HDL-C (-7.14 %) and apoB (-14.8 %). Since the majority of the studied variables were strongly correlated, three factors were identified which explained the majority (52 %) of the total variance in the whole data set. Among them, factor 1, which loaded lipid and adipose variables, explained the 22 % of total variance, showing a statistically significant difference between treatment arms (p = 0.002). CONCLUSIONS: The inclusion of whole soy foods (corresponding to 30 g/day protein) in a lipid-lowering diet significantly improved a relevant set of biomarkers associated with cardiovascular risk.
Entities:
Keywords:
Lipids; Metabolic syndrome and obesity; Soy protein
Authors: E L Thomas; A L Collins; J McCarthy; J Fitzpatrick; G Durighel; A P Goldstone; J D Bell Journal: Eur J Clin Nutr Date: 2010-03-31 Impact factor: 4.016
Authors: G Assmann; P Buono; A Daniele; E Della Valle; E Farinaro; G Ferns; V Krogh; D Kromhout; L Masana; J Merino; G Misciagna; S Panico; G Riccardi; A A Rivellese; F Rozza; F Salvatore; V Salvatore; S Stranges; M Trevisan; B Trimarco; C Vetrani Journal: Nutr Metab Cardiovasc Dis Date: 2014-12 Impact factor: 4.222
Authors: David J A Jenkins; Arash Mirrahimi; Korbua Srichaikul; Claire E Berryman; Li Wang; Amanda Carleton; Shahad Abdulnour; John L Sievenpiper; Cyril W C Kendall; Penny M Kris-Etherton Journal: J Nutr Date: 2010-10-13 Impact factor: 4.798
Authors: F Strollo; C Macchi; I Eberini; M A Masini; M Botta; G Vassilieva; I Nichiporuk; M Monici; D Santucci; F Celotti; P Magni; M Ruscica Journal: J Endocrinol Invest Date: 2018-03-12 Impact factor: 4.256
Authors: Victoria J Vieira-Potter; Tzu-Wen L Cross; Kelly S Swanson; Saurav J Sarma; Zhentian Lei; Lloyd W Sumner; Cheryl S Rosenfeld Journal: Sci Rep Date: 2018-11-15 Impact factor: 4.379